GlassScriptPhysician profile
Amy J Yates
NPI 1407321953
$22,693.66
in general payments reported to CMS, 2019-2025
13 companies · $3,992 in 2025
The $3,992 reported for 2025 was more than what 98% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,174 · 2022: $7,714 · 2023: $2,431 · 2024: $7,382 · 2025: $3,992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,463 · Food and Beverage: $4,257 · Travel and Lodging: $3,169 · Consulting Fee: $1,863 · Education: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,462.51 |
| Food and Beverage | $4,257.12 |
| Travel and Lodging | $3,169.19 |
| Consulting Fee | $1,862.50 |
| Education | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,499.24 | 2021-2025 | Proclaim, Eterna, Ionicrf |
| Medtronic, INC. | $2,112.57 | 2021-2025 | Synchromedii, Intellis Adaptivestim |
| Nalu Medical, INC. | $1,417.35 | 2021-2025 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $1,185.32 | 2025 | Evoke |
| Nevro Corp. | $598.89 | 2021-2024 | Senza |
| Spr Therapeutics, INC | $205.31 | 2023-2025 | Sprint Pns System |
| Globus Medical, INC. | $193.03 | 2025 | Senza |
| Averitas Pharma INC. | $183.01 | 2025 | Qutenza |
| Spinal Simplicity, LLC | $88.90 | 2022 | |
| Vertos Medical, INC. | $84.56 | 2021 | |
| Tersera Therapeutics LLC | $80.44 | 2021-2025 | Prialt |
| Ucb, INC. | $22.83 | 2024 | Fintepla |
| Jazz Pharmaceuticals INC. | $22.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Yates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.